APTARGROUP (AGT.SG) (AGT STU) stock market data APIs
€99.8082
-0.45(-0.5%)
as of November 6, 2025
Try our APIs with
free plan!
APTARGROUP (AGT.SG) Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for AGT.SG.
Prev. Close
99.8082
Open
99.3616
High
100.9471
Low
99.3616
52 wk Range
97.25-164.5169
Market Cap
6 979 M
Dividends (Yield)
0.012
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get APTARGROUP (AGT.SG) data using free add-ons & libraries
Get APTARGROUP (AGT.SG) Fundamental Data
APTARGROUP (AGT.SG) Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-30
- EPS/Forecast: 1.57
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
APTARGROUP (AGT.SG) News
New
Here’s Why Upslope Capital Management Exited its Stake in AptarGroup (ATR)
Upslope Capital Management, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The First quarter was challenging for the fund....
Aptar Declares Quarterly Dividend
CRYSTAL LAKE, Ill., April 17, 2025--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarter...
Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? AptarGroup (ATR), which belongs to the Zac...
Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers
Nanopharm’s SmartTrack™ for Generic Inhalation Products SmartTrack™ aims to reduce the need for clinical studies in generic drug product approvals CRYSTAL LAKE, Ill., April 16, 2025--(BUSINESS...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
